New Data on Risk Factors and Treatment Regimens for Patients With Neovascular AMD and DME

from Medical News Podcast · host PeerDirect Publishing

Drs. Vakharia and Danzig highlight new AAO 2025 data on high-dose aflibercept, sleep apnea as a potential AMD risk factor, and an AI-guided anti-VEGF regimen that cuts injections while maintaining vision. Together, these advances point toward more personalized, efficient care for patients with neovascular AMD and DME.

Episode metadata supplied by the publisher feed · Published Mar 5, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

New Data on Risk Factors and Treatment Regimens for Patients With Neovascular AMD and DME

0:00 9:50

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical News Podcast?

This episode is 9 minutes long.

When was this Medical News Podcast episode published?

This episode was published on March 5, 2026.

Can I download this Medical News Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!